Clinical Evaluation of Safoof-e-Darchini ( Cinnamomum zeylanicum Blum . ) in Primary Hyperlipidaemia

A single blind standard controlled study was designed to evaluate the efficacy of Safoof-e-Darchini in the management of Primary Hyperlipidaemia. The study was conducted at ZVM College Pune. Before starting study ethical clearance was obtained from Ethical Committee. Sixty diagnosed patients were selected on the basis of inclusion criterion. Patients were randomly divided into two groups ‘A’ and ‘B’ comprising 30 patients in each group. In group ‘A’ test drug was given in a dose of 3 gram twice a day whereas in group ‘B’ standard drug Atorvastatin 20 mg was given once a day for the period of 60 days. Assessment of efficacy was done on the basis of objective parameters. In this study both test and control group exhibited significant hypolipidaemic activity (P<0.001).

[1]  R. Barthwal,et al.  Aqueous Bark Extract of Cinnamomum Zeylanicum : A Potential Therapeutic Agent for Streptozotocin- Induced Type 1 Diabetes Mellitus (T1DM) Rats , 2012 .

[2]  Jeff G. Wang,et al.  The effect of cinnamon extract on insulin resistance parameters in polycystic ovary syndrome: a pilot study. , 2007, Fertility and sterility.

[3]  M. Abdollahi,et al.  Anti Oxidative Stress Potential of Cinnamon (Cinnamomum zeylanicum) in Operating Room Personnel; A Before/After Cross Sectional Clinical Trial , 2007 .

[4]  M. Wolters,et al.  Effects of a cinnamon extract on plasma glucose, HbA1c, and serum lipids in diabetes mellitus type 2 , 2006, European journal of clinical investigation.

[5]  W. Wodzig,et al.  Cinnamon supplementation does not improve glycemic control in postmenopausal type 2 diabetes patients. , 2006, The Journal of nutrition.

[6]  E. Verspohl,et al.  Antidiabetic effect of Cinnamomum cassia and Cinnamomum zeylanicum In vivo and In vitro , 2005, Phytotherapy research : PTR.

[7]  D. Bagchi,et al.  Effects of a novel formulation of essential oils on glucose– insulin metabolism in diabetic and hypertensive rats: a pilot study , 2005, Diabetes, obesity & metabolism.

[8]  Alam Khan,et al.  Cinnamon improves glucose and lipids of people with type 2 diabetes. , 2003, Diabetes care.

[9]  Hoi-Seon Lee,et al.  Suppression effect of Cinnamomum cassia bark-derived component on nitric oxide synthase. , 2002, Journal of agricultural and food chemistry.

[10]  M. Polansky,et al.  Insulin-like biological activity of culinary and medicinal plant aqueous extracts in vitro. , 2000, Journal of agricultural and food chemistry.

[11]  K. Erbil,et al.  The Evaluation of Long‐term Effects of Cinnamon Bark and Olive Leaf on Toxicity Induced by Streptozotocin Administration to Rats , 1999, The Journal of pharmacy and pharmacology.

[12]  Richard A. Anderson,et al.  Regulation of PTP-1 and Insulin Receptor Kinase by Fractions from Cinnamon: Implications for Cinnamon Regulation of Insulin Signalling , 1998, Hormone Research in Paediatrics.

[13]  C. Bailey,et al.  Traditional Plant Medicines as Treatments for Diabetes , 1989, Diabetes Care.

[14]  R. W. Hughes.  Current medical diagnosis and treatment , 1978 .

[15]  Talal A. Zari,et al.  Long-term effects of Cinnamomum zeylanicum Blume oil on some physiological parameters in streptozotocin-diabetic and non-diabetic rats , 2009 .

[16]  C. Bailey,et al.  Evaluation of traditional plant treatments for diabetes: Studies in streptozotocin diabetic mice , 2007, Acta diabetologia latina.

[17]  A. Kar,et al.  Comparative evaluation of hypoglycaemic activity of some Indian medicinal plants in alloxan diabetic rats. , 2003, Journal of ethnopharmacology.

[18]  M. Farnier,et al.  Diabetes: Statins, fibrates, or both? , 2001, Current atherosclerosis reports.

[19]  Lee Goldman,et al.  Cecil Textbook of Medicine , 1985 .